ReP USP - Resultado da busca

Artigo de periodico
ARG2 single-nucleotide polymorphism rs3742879 affects plasma arginase 2 levels, nitric oxide formation and antihypertensive therapy response in preeclampsia (2022)
Luizon, Marcelo Rizzatti; Pinto-Souza, Caroline C.; Coeli-Lacchini, Fernanda Borchers; Lacchini, Riccardo ; Cavalli, Ricardo de Carvalho; Sandrim, Valéria Cristina
Source: Pharmacogenomics. Unidades: FMRP, EERP
Subjects: POLIMORFISMO, HIPERTENSÃO, ÓXIDO NÍTRICO, NITRITOS, FARMACOGENÉTICA, PRÉ-ECLÂMPSIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUIZON, Marcelo Rizzatti et al. ARG2 single-nucleotide polymorphism rs3742879 affects plasma arginase 2 levels, nitric oxide formation and antihypertensive therapy response in preeclampsia. Pharmacogenomics, v. 23, n. 13, p. 713-722, 2022Tradução . . Disponível em: https://doi.org/10.2217/pgs-2022-0079. Acesso em: 10 nov. 2024.
APA
Luizon, M. R., Pinto-Souza, C. C., Coeli-Lacchini, F. B., Lacchini, R., Cavalli, R. de C., & Sandrim, V. C. (2022). ARG2 single-nucleotide polymorphism rs3742879 affects plasma arginase 2 levels, nitric oxide formation and antihypertensive therapy response in preeclampsia. Pharmacogenomics, 23( 13), 713-722. doi:10.2217/pgs-2022-0079
NLM
Luizon MR, Pinto-Souza CC, Coeli-Lacchini FB, Lacchini R, Cavalli R de C, Sandrim VC. ARG2 single-nucleotide polymorphism rs3742879 affects plasma arginase 2 levels, nitric oxide formation and antihypertensive therapy response in preeclampsia [Internet]. Pharmacogenomics. 2022 ; 23( 13): 713-722.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2217/pgs-2022-0079
Vancouver
Luizon MR, Pinto-Souza CC, Coeli-Lacchini FB, Lacchini R, Cavalli R de C, Sandrim VC. ARG2 single-nucleotide polymorphism rs3742879 affects plasma arginase 2 levels, nitric oxide formation and antihypertensive therapy response in preeclampsia [Internet]. Pharmacogenomics. 2022 ; 23( 13): 713-722.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2217/pgs-2022-0079
Artigo de periodico
NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia (2021)
Pereira, Daniela A.; Sandrim, Valeria C.; Palei, Ana C.; Amaral, Lorena M.; Belo, Vanessa A.; Lacchini, Riccardo ; Cavalli, Ricardo de Carvalho; Tanus-Santos, José Eduardo ; Luizon, Marcelo R.
Source: Pharmacogenomics. Unidades: EERP, FMRP
Subjects: FÁRMACOS (SISTEMA CARDIOVASCULAR), CITOCINAS, ÓXIDO NÍTRICO, POLIMORFISMO, PRÉ-ECLÂMPSIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Daniela A. et al. NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia. Pharmacogenomics, v. 22, n. 8, p. 451-464, 2021Tradução . . Disponível em: https://doi.org/10.2217/pgs-2021-0006. Acesso em: 10 nov. 2024.
APA
Pereira, D. A., Sandrim, V. C., Palei, A. C., Amaral, L. M., Belo, V. A., Lacchini, R., et al. (2021). NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia. Pharmacogenomics, 22( 8), 451-464. doi:10.2217/pgs-2021-0006
NLM
Pereira DA, Sandrim VC, Palei AC, Amaral LM, Belo VA, Lacchini R, Cavalli R de C, Tanus-Santos JE, Luizon MR. NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia [Internet]. Pharmacogenomics. 2021 ; 22( 8): 451-464.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2217/pgs-2021-0006
Vancouver
Pereira DA, Sandrim VC, Palei AC, Amaral LM, Belo VA, Lacchini R, Cavalli R de C, Tanus-Santos JE, Luizon MR. NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia [Internet]. Pharmacogenomics. 2021 ; 22( 8): 451-464.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2217/pgs-2021-0006
Artigo de periodico
C>T (rs17035945) polymorphism of TIMP-4 protects against preeclampsia (2019)
Sandrim, Valéria Cristina ; Luizon, Marcelo Rizzatti ; Machado, Jackeline Souza Rangel ; Cavalli, Ricardo de Carvalho
Source: Journal Journal of Obstetrics and Gynaecology. Unidade: FMRP
Subjects: POLIMORFISMO, PRÉ-ECLÂMPSIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANDRIM, Valéria Cristina et al. C>T (rs17035945) polymorphism of TIMP-4 protects against preeclampsia. Journal Journal of Obstetrics and Gynaecology, v. 39, n. 1, p. 135-137, 2019Tradução . . Disponível em: https://doi.org/10.1080/01443615.2018.1460746. Acesso em: 10 nov. 2024.
APA
Sandrim, V. C., Luizon, M. R., Machado, J. S. R., & Cavalli, R. de C. (2019). C>T (rs17035945) polymorphism of TIMP-4 protects against preeclampsia. Journal Journal of Obstetrics and Gynaecology, 39( 1), 135-137. doi:10.1080/01443615.2018.1460746
NLM
Sandrim VC, Luizon MR, Machado JSR, Cavalli R de C. C>T (rs17035945) polymorphism of TIMP-4 protects against preeclampsia [Internet]. Journal Journal of Obstetrics and Gynaecology. 2019 ; 39( 1): 135-137.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1080/01443615.2018.1460746
Vancouver
Sandrim VC, Luizon MR, Machado JSR, Cavalli R de C. C>T (rs17035945) polymorphism of TIMP-4 protects against preeclampsia [Internet]. Journal Journal of Obstetrics and Gynaecology. 2019 ; 39( 1): 135-137.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1080/01443615.2018.1460746
Artigo de periodico
Pharmacogenetics in the treatment of pre-eclampsia: current findings, challenges and perspectives (2017)
Luizon, Marcelo R; Palei, Ana C. T; Cavalli, Ricardo de Carvalho; Sandrim, Valeria C
Source: Pharmacogenomics. Unidade: FMRP
Subjects: FARMACOGENÉTICA, HIPERTENSÃO NA GRAVIDEZ, PRÉ-ECLÂMPSIA, HIPERTENSÃO, POLIMORFISMO, GENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUIZON, Marcelo R et al. Pharmacogenetics in the treatment of pre-eclampsia: current findings, challenges and perspectives. Pharmacogenomics, v. 18, n. 6, p. 571-583, 2017Tradução . . Disponível em: https://doi.org/10.2217/pgs-2016-0198. Acesso em: 10 nov. 2024.
APA
Luizon, M. R., Palei, A. C. T., Cavalli, R. de C., & Sandrim, V. C. (2017). Pharmacogenetics in the treatment of pre-eclampsia: current findings, challenges and perspectives. Pharmacogenomics, 18( 6), 571-583. doi:10.2217/pgs-2016-0198
NLM
Luizon MR, Palei ACT, Cavalli R de C, Sandrim VC. Pharmacogenetics in the treatment of pre-eclampsia: current findings, challenges and perspectives [Internet]. Pharmacogenomics. 2017 ; 18( 6): 571-583.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2217/pgs-2016-0198
Vancouver
Luizon MR, Palei ACT, Cavalli R de C, Sandrim VC. Pharmacogenetics in the treatment of pre-eclampsia: current findings, challenges and perspectives [Internet]. Pharmacogenomics. 2017 ; 18( 6): 571-583.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2217/pgs-2016-0198
Artigo de periodico
Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy (2017)
Luizon, Marcelo Rizzatti; Palei, Ana Carolina Taveiros; Belo, V. A.; Amaral, L. M.; Lacchini, Riccardo ; Duarte, Geraldo; Cavalli, Ricardo de Carvalho; Sandrim, Valéria Cristina; Tanus-Santos, José Eduardo
Source: The Pharmacogenomics Journal. Unidades: EERP, FMRP
Subjects: POLIMORFISMO, FÁRMACOS (SISTEMA CARDIOVASCULAR), HIPERTENSÃO NA GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUIZON, Marcelo Rizzatti et al. Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. The Pharmacogenomics Journal, v. 17, n. 5, p. 427-434, 2017Tradução . . Disponível em: https://doi.org/10.1038/tpj.2016.35. Acesso em: 10 nov. 2024.
APA
Luizon, M. R., Palei, A. C. T., Belo, V. A., Amaral, L. M., Lacchini, R., Duarte, G., et al. (2017). Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. The Pharmacogenomics Journal, 17( 5), 427-434. doi:10.1038/tpj.2016.35
NLM
Luizon MR, Palei ACT, Belo VA, Amaral LM, Lacchini R, Duarte G, Cavalli R de C, Sandrim VC, Tanus-Santos JE. Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy [Internet]. The Pharmacogenomics Journal. 2017 ; 17( 5): 427-434.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1038/tpj.2016.35
Vancouver
Luizon MR, Palei ACT, Belo VA, Amaral LM, Lacchini R, Duarte G, Cavalli R de C, Sandrim VC, Tanus-Santos JE. Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy [Internet]. The Pharmacogenomics Journal. 2017 ; 17( 5): 427-434.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1038/tpj.2016.35
Artigo de periodico
Pathogenesis of polycystic ovary syndrome: multifactorial assessment from the foetal stage to menopause (2015)
Melo, Anderson Sanches de; Dias, Sabrine Vilan; Cavalli, Ricardo de Carvalho; Cardoso, Viviane Cunha; Bettiol, Heloisa; Barbieri, Marco Antonio; Ferriani, Rui Alberto; Vieira, Carolina Sales
Source: Reproduction. Unidade: FMRP
Subjects: SÍNDROME DO OVÁRIO POLICÍSTICO, VARIAÇÃO GENÉTICA, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MELO, Anderson Sanches de et al. Pathogenesis of polycystic ovary syndrome: multifactorial assessment from the foetal stage to menopause. Reproduction, v. 150, n. 1, p. R11-R24, 2015Tradução . . Disponível em: https://doi.org/10.1530/REP-14-0499. Acesso em: 10 nov. 2024.
APA
Melo, A. S. de, Dias, S. V., Cavalli, R. de C., Cardoso, V. C., Bettiol, H., Barbieri, M. A., et al. (2015). Pathogenesis of polycystic ovary syndrome: multifactorial assessment from the foetal stage to menopause. Reproduction, 150( 1), R11-R24. doi:10.1530/REP-14-0499
NLM
Melo AS de, Dias SV, Cavalli R de C, Cardoso VC, Bettiol H, Barbieri MA, Ferriani RA, Vieira CS. Pathogenesis of polycystic ovary syndrome: multifactorial assessment from the foetal stage to menopause [Internet]. Reproduction. 2015 ; 150( 1): R11-R24.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1530/REP-14-0499
Vancouver
Melo AS de, Dias SV, Cavalli R de C, Cardoso VC, Bettiol H, Barbieri MA, Ferriani RA, Vieira CS. Pathogenesis of polycystic ovary syndrome: multifactorial assessment from the foetal stage to menopause [Internet]. Reproduction. 2015 ; 150( 1): R11-R24.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1530/REP-14-0499
Trabalho de evento-resumo periodico
TNF-2 gene -308 polymorphism among women with preterm delivery from two Brazilian cohorts with different socioeconomic profiles (BRISA Birth Cohort, Brazil) (2015)
Freitas, Perla Lopes de; Cavalli, Ricardo de Carvalho; Silva, Antonio Augusto Moura da; Bettiol, Heloisa; Barbieri, Marco Antonio; Cardoso, Viviane Cunha; Batista, Rosângela Fernandes Lucena; Pereira, Silma Regina Ferreira
Source: Journal of Developmental Origins of Health and Disease. Conference titles: World Congress on Developmental Origins of Health and Disease. Unidade: FMRP
Subjects: POLIMORFISMO, GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREITAS, Perla Lopes de et al. TNF-2 gene -308 polymorphism among women with preterm delivery from two Brazilian cohorts with different socioeconomic profiles (BRISA Birth Cohort, Brazil). Journal of Developmental Origins of Health and Disease. Cambridge: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 10 nov. 2024. , 2015
APA
Freitas, P. L. de, Cavalli, R. de C., Silva, A. A. M. da, Bettiol, H., Barbieri, M. A., Cardoso, V. C., et al. (2015). TNF-2 gene -308 polymorphism among women with preterm delivery from two Brazilian cohorts with different socioeconomic profiles (BRISA Birth Cohort, Brazil). Journal of Developmental Origins of Health and Disease. Cambridge: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Freitas PL de, Cavalli R de C, Silva AAM da, Bettiol H, Barbieri MA, Cardoso VC, Batista RFL, Pereira SRF. TNF-2 gene -308 polymorphism among women with preterm delivery from two Brazilian cohorts with different socioeconomic profiles (BRISA Birth Cohort, Brazil). Journal of Developmental Origins of Health and Disease. 2015 ; 6 S172.[citado 2024 nov. 10 ]
Vancouver
Freitas PL de, Cavalli R de C, Silva AAM da, Bettiol H, Barbieri MA, Cardoso VC, Batista RFL, Pereira SRF. TNF-2 gene -308 polymorphism among women with preterm delivery from two Brazilian cohorts with different socioeconomic profiles (BRISA Birth Cohort, Brazil). Journal of Developmental Origins of Health and Disease. 2015 ; 6 S172.[citado 2024 nov. 10 ]
Artigo de periodico
Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy (2014)
Luizon, M. R.; Palei, A. C. T.; Sandrim, V. C.; Amaral, L. M.; Machado, J. S. R.; Lacchini, Riccardo ; Cavalli, Ricardo de Carvalho; Duarte, Geraldo; Tanus-Santos, José Eduardo
Source: The Pharmacogenomics Journal. Unidades: EERP, FMRP
Subjects: INIBIDORES DE ENZIMAS, METALOPROTEINASES, POLIMORFISMO, HIPERTENSÃO NA GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUIZON, M. R. et al. Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. The Pharmacogenomics Journal, v. 14, n. 6, p. 535-541, 2014Tradução . . Disponível em: https://doi.org/10.1038/tpj.2014.26. Acesso em: 10 nov. 2024.
APA
Luizon, M. R., Palei, A. C. T., Sandrim, V. C., Amaral, L. M., Machado, J. S. R., Lacchini, R., et al. (2014). Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. The Pharmacogenomics Journal, 14( 6), 535-541. doi:10.1038/tpj.2014.26
NLM
Luizon MR, Palei ACT, Sandrim VC, Amaral LM, Machado JSR, Lacchini R, Cavalli R de C, Duarte G, Tanus-Santos JE. Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy [Internet]. The Pharmacogenomics Journal. 2014 ; 14( 6): 535-541.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1038/tpj.2014.26
Vancouver
Luizon MR, Palei ACT, Sandrim VC, Amaral LM, Machado JSR, Lacchini R, Cavalli R de C, Duarte G, Tanus-Santos JE. Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy [Internet]. The Pharmacogenomics Journal. 2014 ; 14( 6): 535-541.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1038/tpj.2014.26
Artigo de periodico
Polymorphisms of the adiponectin gene in gestational hypertension and pre-eclampsia (2014)
Machado, J. S. R.; Palei, Ana Carolina Taveiros; Amaral, L. M.; Bueno, A. C.; Antonini, Sonir Roberto Rauber; Duarte, Geraldo; Tanus-Santos, José Eduardo; Sandrim, Valéria Cristina; Cavalli, Ricardo de Carvalho
Source: Journal of Human Hypertension. Unidade: FMRP
Subjects: ADIPONECTINA, HIPERTENSÃO NA GRAVIDEZ, POLIMORFISMO, PRÉ-ECLÂMPSIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO, J. S. R. et al. Polymorphisms of the adiponectin gene in gestational hypertension and pre-eclampsia. Journal of Human Hypertension, v. 28, n. 2, p. 128-132, 2014Tradução . . Disponível em: https://doi.org/10.1038/jhh.2013.53. Acesso em: 10 nov. 2024.
APA
Machado, J. S. R., Palei, A. C. T., Amaral, L. M., Bueno, A. C., Antonini, S. R. R., Duarte, G., et al. (2014). Polymorphisms of the adiponectin gene in gestational hypertension and pre-eclampsia. Journal of Human Hypertension, 28( 2), 128-132. doi:10.1038/jhh.2013.53
NLM
Machado JSR, Palei ACT, Amaral LM, Bueno AC, Antonini SRR, Duarte G, Tanus-Santos JE, Sandrim VC, Cavalli R de C. Polymorphisms of the adiponectin gene in gestational hypertension and pre-eclampsia [Internet]. Journal of Human Hypertension. 2014 ; 28( 2): 128-132.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1038/jhh.2013.53
Vancouver
Machado JSR, Palei ACT, Amaral LM, Bueno AC, Antonini SRR, Duarte G, Tanus-Santos JE, Sandrim VC, Cavalli R de C. Polymorphisms of the adiponectin gene in gestational hypertension and pre-eclampsia [Internet]. Journal of Human Hypertension. 2014 ; 28( 2): 128-132.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1038/jhh.2013.53
Artigo de periodico
Maternal iNOS genetic polymorphisms and hypertensive disorders of pregnancy (2012)
Amaral, L. M.; Palei, A. C. T.; Sandrim, V. C.; Luizon, M. R.; Cavalli, Ricardo de Carvalho; Duarte, Geraldo; Tanus-Santos, José Eduardo
Source: Journal of Human Hypertension. Unidade: FMRP
Subjects: HIPERTENSÃO NA GRAVIDEZ, ÓXIDO NÍTRICO, POLIMORFISMO, PRÉ-ECLÂMPSIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMARAL, L. M. et al. Maternal iNOS genetic polymorphisms and hypertensive disorders of pregnancy. Journal of Human Hypertension, v. 26, n. 9, p. 547-552, 2012Tradução . . Disponível em: https://doi.org/10.1038/jhh.2011.65. Acesso em: 10 nov. 2024.
APA
Amaral, L. M., Palei, A. C. T., Sandrim, V. C., Luizon, M. R., Cavalli, R. de C., Duarte, G., & Tanus-Santos, J. E. (2012). Maternal iNOS genetic polymorphisms and hypertensive disorders of pregnancy. Journal of Human Hypertension, 26( 9), 547-552. doi:10.1038/jhh.2011.65
NLM
Amaral LM, Palei ACT, Sandrim VC, Luizon MR, Cavalli R de C, Duarte G, Tanus-Santos JE. Maternal iNOS genetic polymorphisms and hypertensive disorders of pregnancy [Internet]. Journal of Human Hypertension. 2012 ; 26( 9): 547-552.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1038/jhh.2011.65
Vancouver
Amaral LM, Palei ACT, Sandrim VC, Luizon MR, Cavalli R de C, Duarte G, Tanus-Santos JE. Maternal iNOS genetic polymorphisms and hypertensive disorders of pregnancy [Internet]. Journal of Human Hypertension. 2012 ; 26( 9): 547-552.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1038/jhh.2011.65
Artigo de periodico
Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy (2011)
Palei, A. C. T.; Sandrim, V. C.; Amaral, L. M.; Machado, J. S. R.; Cavalli, Ricardo de Carvalho; Lacchini, Riccardo ; Duarte, Geraldo; Tanus-Santos, José Eduardo
Source: The Pharmacogenomics Journal. Unidade: FMRP
Subjects: POLIMORFISMO, HIPERTENSÃO NA GRAVIDEZ (TERAPIA), PRÉ-ECLÂMPSIA, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PALEI, A. C. T. et al. Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. The Pharmacogenomics Journal, v. 3, n. 3, 2011Tradução . . Disponível em: https://doi.org/10.1038/tpj.2011.31. Acesso em: 10 nov. 2024.
APA
Palei, A. C. T., Sandrim, V. C., Amaral, L. M., Machado, J. S. R., Cavalli, R. de C., Lacchini, R., et al. (2011). Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. The Pharmacogenomics Journal, 3( 3). doi:10.1038/tpj.2011.31
NLM
Palei ACT, Sandrim VC, Amaral LM, Machado JSR, Cavalli R de C, Lacchini R, Duarte G, Tanus-Santos JE. Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy [Internet]. The Pharmacogenomics Journal. 2011 ; 3( 3):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1038/tpj.2011.31
Vancouver
Palei ACT, Sandrim VC, Amaral LM, Machado JSR, Cavalli R de C, Lacchini R, Duarte G, Tanus-Santos JE. Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy [Internet]. The Pharmacogenomics Journal. 2011 ; 3( 3):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1038/tpj.2011.31
Artigo de periodico
Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia (2010)
Sandrim, Valéria Cristina; Palei, Ana Carolina Taveiros; Sertorio, Jonas T.; Cavalli, Ricardo de Carvalho; Duarte, Geraldo; Tanus-Santos, José Eduardo
Source: Molecular Human Reproduction. Unidade: FMRP
Subjects: PRÉ-ECLÂMPSIA, ÓXIDO NÍTRICO, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANDRIM, Valéria Cristina et al. Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia. Molecular Human Reproduction, v. 16, n. 7, p. 506-510, 2010Tradução . . Disponível em: https://doi.org/10.1093/molehr/gaq030. Acesso em: 10 nov. 2024.
APA
Sandrim, V. C., Palei, A. C. T., Sertorio, J. T., Cavalli, R. de C., Duarte, G., & Tanus-Santos, J. E. (2010). Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia. Molecular Human Reproduction, 16( 7), 506-510. doi:10.1093/molehr/gaq030
NLM
Sandrim VC, Palei ACT, Sertorio JT, Cavalli R de C, Duarte G, Tanus-Santos JE. Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia [Internet]. Molecular Human Reproduction. 2010 ; 16( 7): 506-510.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1093/molehr/gaq030
Vancouver
Sandrim VC, Palei ACT, Sertorio JT, Cavalli R de C, Duarte G, Tanus-Santos JE. Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia [Internet]. Molecular Human Reproduction. 2010 ; 16( 7): 506-510.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1093/molehr/gaq030
Artigo de periodico
eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestacional hypertension (2010)
Sandrim, V. C.; Palei, A. C. T.; Luizon, M. R.; Izidoro-Toledo, T. C.; Cavalli, Ricardo de Carvalho; Tanus-Santos, José Eduardo
Source: The Pharmacogenomics Journal. Unidade: FMRP
Subjects: POLIMORFISMO, HIPERTENSÃO NA GRAVIDEZ, FARMACOGENÉTICA, PRÉ-ECLÂMPSIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANDRIM, V. C. et al. eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestacional hypertension. The Pharmacogenomics Journal, v. 10, n. 1, p. 40-45, 2010Tradução . . Disponível em: https://doi.org/10.1038/tpj.2009.38. Acesso em: 10 nov. 2024.
APA
Sandrim, V. C., Palei, A. C. T., Luizon, M. R., Izidoro-Toledo, T. C., Cavalli, R. de C., & Tanus-Santos, J. E. (2010). eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestacional hypertension. The Pharmacogenomics Journal, 10( 1), 40-45. doi:10.1038/tpj.2009.38
NLM
Sandrim VC, Palei ACT, Luizon MR, Izidoro-Toledo TC, Cavalli R de C, Tanus-Santos JE. eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestacional hypertension [Internet]. The Pharmacogenomics Journal. 2010 ; 10( 1): 40-45.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1038/tpj.2009.38
Vancouver
Sandrim VC, Palei ACT, Luizon MR, Izidoro-Toledo TC, Cavalli R de C, Tanus-Santos JE. eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestacional hypertension [Internet]. The Pharmacogenomics Journal. 2010 ; 10( 1): 40-45.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1038/tpj.2009.38
Artigo de periodico
eNOS haptolotypes associated with gestational hypertension on preeclampsia (2008)
Sandrim, Valéria C.; Palei, Ana C. T.; Cavalli, Ricardo Carvalho; Araújo, Francielle M.; Ramos, Ester Silveira; Duarte, Geraldo; Tanus-Santos, José Eduardo
Source: Pharmacogenomics. Unidade: FMRP
Subjects: POLIMORFISMO, HIPERTENSÃO NA GRAVIDEZ, PRÉ-ECLÂMPSIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANDRIM, Valéria C. et al. eNOS haptolotypes associated with gestational hypertension on preeclampsia. Pharmacogenomics, v. 9, n. 10, p. 1467-1473, 2008Tradução . . Disponível em: https://doi.org/10.2217/14622416.9.10.1467. Acesso em: 10 nov. 2024.
APA
Sandrim, V. C., Palei, A. C. T., Cavalli, R. C., Araújo, F. M., Ramos, E. S., Duarte, G., & Tanus-Santos, J. E. (2008). eNOS haptolotypes associated with gestational hypertension on preeclampsia. Pharmacogenomics, 9( 10), 1467-1473. doi:10.2217/14622416.9.10.1467
NLM
Sandrim VC, Palei ACT, Cavalli RC, Araújo FM, Ramos ES, Duarte G, Tanus-Santos JE. eNOS haptolotypes associated with gestational hypertension on preeclampsia [Internet]. Pharmacogenomics. 2008 ; 9( 10): 1467-1473.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2217/14622416.9.10.1467
Vancouver
Sandrim VC, Palei ACT, Cavalli RC, Araújo FM, Ramos ES, Duarte G, Tanus-Santos JE. eNOS haptolotypes associated with gestational hypertension on preeclampsia [Internet]. Pharmacogenomics. 2008 ; 9( 10): 1467-1473.[citado 2024 nov. 10 ] Available from: https://doi.org/10.2217/14622416.9.10.1467
Trabalho de evento-resumo periodico
Gestational hypertensive disorders, newborn birh weigth and maternal IGF2/Apal and H19/Rsal polymorphisms (2007)
Araújo, F. M.; Soares, M. R.; Gomes, M. V. M.; Duarte, Geraldo; Marcondes, C. R.; Vozzi, P. A.; Lôbo, Raysildo Barbosa; Ramos, Ester Silveira
Source: European Journal of Human Genetics. Conference titles: European Human Genetics Conference. Unidade: FMRP
Subjects: POLIMORFISMO, HIPERTENSÃO NA GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAÚJO, F. M. et al. Gestational hypertensive disorders, newborn birh weigth and maternal IGF2/Apal and H19/Rsal polymorphisms. European Journal of Human Genetics. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 10 nov. 2024. , 2007
APA
Araújo, F. M., Soares, M. R., Gomes, M. V. M., Duarte, G., Marcondes, C. R., Vozzi, P. A., et al. (2007). Gestational hypertensive disorders, newborn birh weigth and maternal IGF2/Apal and H19/Rsal polymorphisms. European Journal of Human Genetics. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Araújo FM, Soares MR, Gomes MVM, Duarte G, Marcondes CR, Vozzi PA, Lôbo RB, Ramos ES. Gestational hypertensive disorders, newborn birh weigth and maternal IGF2/Apal and H19/Rsal polymorphisms. European Journal of Human Genetics. 2007 ; 15 251.[citado 2024 nov. 10 ]
Vancouver
Araújo FM, Soares MR, Gomes MVM, Duarte G, Marcondes CR, Vozzi PA, Lôbo RB, Ramos ES. Gestational hypertensive disorders, newborn birh weigth and maternal IGF2/Apal and H19/Rsal polymorphisms. European Journal of Human Genetics. 2007 ; 15 251.[citado 2024 nov. 10 ]

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Date published

Subjects

Source title

Funding Agencies

Indexado em

Non normalized affiliation